company background image
LBPH

Longboard Pharmaceuticals NasdaqGM:LBPH Stock Report

Last Price

US$5.14

Market Cap

US$88.5m

7D

9.4%

1Y

-12.9%

Updated

27 Nov, 2022

Data

Company Financials +
LBPH fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

LBPH Stock Overview

Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases.

Longboard Pharmaceuticals, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Longboard Pharmaceuticals
Historical stock prices
Current Share PriceUS$5.14
52 Week HighUS$6.47
52 Week LowUS$2.70
Beta0
1 Month Change73.65%
3 Month Change40.82%
1 Year Change-12.88%
3 Year Changen/a
5 Year Changen/a
Change since IPO-69.13%

Recent News & Updates

Recent updates

Companies Like Longboard Pharmaceuticals (NASDAQ:LBPH) Are In A Position To Invest In Growth

Sep 10
Companies Like Longboard Pharmaceuticals (NASDAQ:LBPH) Are In A Position To Invest In Growth

We're Hopeful That Longboard Pharmaceuticals (NASDAQ:LBPH) Will Use Its Cash Wisely

May 28
We're Hopeful That Longboard Pharmaceuticals (NASDAQ:LBPH) Will Use Its Cash Wisely

Longboard Pharmaceuticals (NASDAQ:LBPH) Is In A Good Position To Deliver On Growth Plans

Feb 11
Longboard Pharmaceuticals (NASDAQ:LBPH) Is In A Good Position To Deliver On Growth Plans

Here's Why We're Not At All Concerned With Longboard Pharmaceuticals' (NASDAQ:LBPH) Cash Burn Situation

Oct 27
Here's Why We're Not At All Concerned With Longboard Pharmaceuticals' (NASDAQ:LBPH) Cash Burn Situation

Longboard Pharmaceuticals (NASDAQ:LBPH) Is In A Strong Position To Grow Its Business

Jun 12
Longboard Pharmaceuticals (NASDAQ:LBPH) Is In A Strong Position To Grow Its Business

Shareholder Returns

LBPHUS PharmaceuticalsUS Market
7D9.4%1.6%1.3%
1Y-12.9%9.9%-18.5%

Return vs Industry: LBPH underperformed the US Pharmaceuticals industry which returned 9.9% over the past year.

Return vs Market: LBPH exceeded the US Market which returned -18.5% over the past year.

Price Volatility

Is LBPH's price volatile compared to industry and market?
LBPH volatility
LBPH Average Weekly Movement12.0%
Pharmaceuticals Industry Average Movement11.0%
Market Average Movement7.4%
10% most volatile stocks in US Market15.6%
10% least volatile stocks in US Market3.3%

Stable Share Price: LBPH is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 12% a week.

Volatility Over Time: LBPH's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
202022Kevin Lindhttps://www.longboardpharma.com

Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company’s lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical product candidates include LP659 and LP143, which focuses on developing therapies for multiple neurological diseases.

Longboard Pharmaceuticals, Inc. Fundamentals Summary

How do Longboard Pharmaceuticals's earnings and revenue compare to its market cap?
LBPH fundamental statistics
Market CapUS$88.49m
Earnings (TTM)-US$41.37m
Revenue (TTM)n/a

0.0x

P/S Ratio

-2.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
LBPH income statement (TTM)
RevenueUS$0
Cost of RevenueUS$0
Gross ProfitUS$0
Other ExpensesUS$41.37m
Earnings-US$41.37m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-2.40
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.6%

How did LBPH perform over the long term?

See historical performance and comparison